As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing - LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing - ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing - Managed communities. As of September 30, 2020, Sabra's real estate properties held for investment included 42,378 beds/units and its unconsolidated joint venture included 7,056 beds/units, spread across the United States and Canada.
IPO Year:
Exchange: NASDAQ
Website: sabrahealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/17/2025 | Buy → Hold | Truist | |
| 1/7/2025 | $20.00 | Mkt Perform → Mkt Outperform | JMP Securities |
| 12/5/2024 | $20.00 | Outperform → Neutral | Mizuho |
| 10/1/2024 | $16.00 → $20.00 | Equal Weight → Overweight | Wells Fargo |
| 9/13/2024 | $17.00 → $20.00 | Neutral → Buy | Citigroup |
| 1/30/2024 | $21.00 | Buy | Deutsche Bank |
| 10/17/2023 | $16.00 | Outperform → Market Perform | BMO Capital Markets |
| 10/16/2023 | $13.00 → $15.00 | Underweight → Equal Weight | Wells Fargo |
| 10/10/2023 | $14.00 → $16.00 | Neutral → Buy | BofA Securities |
| 10/3/2023 | $16.00 | Outperform | Wedbush |
Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held various leadership positions overseeing Sabra's accounting during that time. Ms. Flores has over 15 years of experience in accounting, finance and real estate investments, having previously worked for KBS Realty Advisors and Deloit
IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors. Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided
IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Ann Kono to its Board of Directors. Ms. Kono currently serves as the chief executive officer of Leda Advisory Group, a management consulting firm she founded in January 2019 that partners with startup companies to advise on growth and scale. Prior to founding Leda, Ms. Kono spent 11 years at Ares Management Corporation, where she held the position of Chief Information and Risk Officer, and oversaw Operational, Investment and Enterprise Risks. Ms. Kono also serves on the board of directors of Stable Road Acquisition Company, a position she has held since 2019. M
IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Clifton J. Porter II to its Board of Directors. Clifton J. Porter II currently serves as Senior Vice President of the American Healthcare Association/National Center for Assisted Living and is responsible for leading and executing the Association’s policy and legislative agenda impacting both the skilled nursing and assisted living sectors. Mr. Porter has over 31 years of experience in the long-term care profession, starting in operations as an Administrator in Training in 1989 ultimately leading to the oversight of multiple facilities in a large urban market. I
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2024 were as follows: Net Income: $0.19 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.09x Senior Housing - Leased: 1.36x Behavioral Health, Specialty Hospitals and Other: 3.66x Same store managed senior housing Cash NOI increased 17.9% on a year-over-year basis. As previously announced, in the fourth quarter of 2024, Sabra cl
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 fourth quarter earnings release on February 19, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 fourth quarter results will be held on Thursday, February 20 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/595686468. A digital replay of the call will be available on our website at www.sabrahealth.com. Also, on February 3, 2025, Sabra's board of directors
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today the tax treatment for its 2024 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share Total Ordinary Dividends Non-Qualified Dividends Qualified Dividends Non-Dividend Distributions 02/13/2024 02/29/2024 $ 0.3000000 $ 0.2649911 $ 0.2649911 $ 0.0000000 $ 0.
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2024. THIRD QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2024 were as follows: Net Income: $0.13 FFO: $0.34 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.94x Senior Housing - Leased: 1.37x Behavioral Health, Specialty Hospitals and Other: 3.68x Same store managed senior housing Cash NOI increased 17.8% on a year-over-year basis. As previously announced, in the third quarter of 2024, Sabra close
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 third quarter earnings release on October 31, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 third quarter results will be held on Friday, November 1 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/444925126. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporat
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the second quarter of 2024. SECOND QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2024 were as follows: Net Income: $0.10 FFO: $0.35 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.85x Senior Housing - Leased: 1.35x Behavioral Health, Specialty Hospitals and Other: 3.69x Same store managed senior housing Cash NOI increased 17.7% on a year-over-year basis. Investment activity through June 30, 2024 amounts
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 second quarter earnings release on August 7, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 second quarter results will be held on Thursday, August 8 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/150203568. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corp
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2024. FIRST QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2024 were as follows: Net Income: $0.11 FFO: $0.32 Normalized FFO: $0.34 AFFO: $0.35 Normalized AFFO: $0.35 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.79x (1.79x excluding Provider Relief Funds) Senior Housing - Leased: 1.33x Behavioral Health, Specialty Hospitals and Other: 3.77x On May 8, 2024, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share of commo
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Nareit's REITweek 2025 Investor Conference June 2 – 5, 2025 at the New York Hilton Midtown in New York, New York. Additionally, Talya Nevo-Hacohen, Darrin Smith, and other members of the company, will attend ASHA's 2025 Mid-Year Meeting on June 9 – 10, 2025, at the Omni Interlocken Hotel, in Broom
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Jessica Flores, the company's Chief Accounting Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Deutsche Bank's 2025 Healthcare REIT Summit virtually on April 10, 2025. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsid
Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Talya Nevo-Hacohen, Sabra's Chief Investment Officer, Treasurer and Executive Vice President, has decided to retire effective December 31, 2025 and Darrin Smith, Sabra's Executive Vice President, Investments, is expected to be elevated to the role of Sabra's Chief Investment Officer effective January 1, 2026. Ms. Nevo-Hacohen is expected to remain in a consulting role with Sabra pursuant to a two-year consulting arrangement. Commenting on the CIO transition, Sabra's Chief Executive Officer, President and Chair of the Board, Rick Matros, said, "Talya has been a critical part of our leadership team since our formation
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2024 were as follows: Net Income: $0.19 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.09x Senior Housing - Leased: 1.36x Behavioral Health, Specialty Hospitals and Other: 3.66x Same store managed senior housing Cash NOI increased 17.9% on a year-over-year basis. As previously announced, in the fourth quarter of 2024, Sabra cl
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Citi's 2025 Global Property CEO Conference on March 3-5, 2025 at The Diplomat Beach Resort in Hollywood, Florida. Additionally, Darrin Smith, Eliza Gozar, the company's Senior Vice President of Investments, and other members of the company, will attend the 2025 NIC Spring Conference on March 5-7, 2025, a
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced three promotions within its leadership team. Lukas Hartwich has been promoted to Executive Vice President – Finance after previously serving as Senior Vice President – Finance. Since joining Sabra in October 2021, Mr. Hartwich has made notable contributions across the organization, including through his leadership of Sabra's financial planning and analysis, investor relations, and business intelligence functions. Prior to joining Sabra, Mr. Hartwich spent 15 years at Green Street, a leading independent research and advisory firm concentrated on the commercial real estate industry. Mr. Hartwich grad
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 fourth quarter earnings release on February 19, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 fourth quarter results will be held on Thursday, February 20 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/595686468. A digital replay of the call will be available on our website at www.sabrahealth.com. Also, on February 3, 2025, Sabra's board of directors
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today the tax treatment for its 2024 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share Total Ordinary Dividends Non-Qualified Dividends Qualified Dividends Non-Dividend Distributions 02/13/2024 02/29/2024 $ 0.3000000 $ 0.2649911 $ 0.2649911 $ 0.0000000 $ 0.
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G - Sabra Health Care REIT, Inc. (0001492298) (Subject)
Truist downgraded Sabra Health Care REIT from Buy to Hold
JMP Securities upgraded Sabra Health Care REIT from Mkt Perform to Mkt Outperform and set a new price target of $20.00
Mizuho downgraded Sabra Health Care REIT from Outperform to Neutral and set a new price target of $20.00
Wells Fargo upgraded Sabra Health Care REIT from Equal Weight to Overweight and set a new price target of $20.00 from $16.00 previously
Citigroup upgraded Sabra Health Care REIT from Neutral to Buy and set a new price target of $20.00 from $17.00 previously
Deutsche Bank initiated coverage of Sabra Health Care REIT with a rating of Buy and set a new price target of $21.00
BMO Capital Markets downgraded Sabra Health Care REIT from Outperform to Market Perform and set a new price target of $16.00
Wells Fargo upgraded Sabra Health Care REIT from Underweight to Equal Weight and set a new price target of $15.00 from $13.00 previously
BofA Securities upgraded Sabra Health Care REIT from Neutral to Buy and set a new price target of $16.00 from $14.00 previously
Wedbush initiated coverage of Sabra Health Care REIT with a rating of Outperform and set a new price target of $16.00
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
144 - Sabra Health Care REIT, Inc. (0001492298) (Subject)
10-Q - Sabra Health Care REIT, Inc. (0001492298) (Filer)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
DEFA14A - Sabra Health Care REIT, Inc. (0001492298) (Filer)
DEF 14A - Sabra Health Care REIT, Inc. (0001492298) (Filer)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
10-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
SCHEDULE 13G - Sabra Health Care REIT, Inc. (0001492298) (Subject)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)